These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17717562)

  • 1. Racial and survival paradoxes in chronic kidney disease.
    Kalantar-Zadeh K; Kovesdy CP; Derose SF; Horwich TB; Fonarow GC
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):493-506. PubMed ID: 17717562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual roles of obesity in chronic kidney disease: a review of the current literature.
    Rhee CM; Ahmadi SF; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):208-16. PubMed ID: 26999023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor paradox in wasting diseases.
    Kalantar-Zadeh K; Horwich TB; Oreopoulos A; Kovesdy CP; Younessi H; Anker SD; Morley JE
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):433-42. PubMed ID: 17563461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
    Kalantar-Zadeh K; Block G; Humphreys MH; Kopple JD
    Kidney Int; 2003 Mar; 63(3):793-808. PubMed ID: 12631061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity paradox in patients on maintenance dialysis.
    Kalantar-Zadeh K; Kopple JD
    Contrib Nephrol; 2006; 151():57-69. PubMed ID: 16929133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival disparities within American and Israeli dialysis populations: learning from similarities and distinctions across race and ethnicity.
    Kalantar-Zadeh K; Golan E; Shohat T; Streja E; Norris KC; Kopple JD
    Semin Dial; 2010; 23(6):586-94. PubMed ID: 21175833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease.
    Palit S; Chonchol M; Cheung AK; Kaufman J; Smits G; Kendrick J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):934-40. PubMed ID: 25979975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is so bad about reverse epidemiology anyway?
    Kalantar-Zadeh K
    Semin Dial; 2007; 20(6):593-601. PubMed ID: 17991210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of chronic kidney disease].
    Noël D; Landais P
    Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum lipids and survival in hemodialysis patients and impact of race.
    Kilpatrick RD; McAllister CJ; Kovesdy CP; Derose SF; Kopple JD; Kalantar-Zadeh K
    J Am Soc Nephrol; 2007 Jan; 18(1):293-303. PubMed ID: 17167113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do patients with chronic kidney disease get optimal cardiovascular risk reduction?
    Elliott MK; McCaughan JA; Fogarty DG
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):267-74. PubMed ID: 24694581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival advantages of obesity in dialysis patients.
    Kalantar-Zadeh K; Abbott KC; Salahudeen AK; Kilpatrick RD; Horwich TB
    Am J Clin Nutr; 2005 Mar; 81(3):543-54. PubMed ID: 15755821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
    Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
    Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic Disparities in CKD in the Netherlands: The Healthy Life in an Urban Setting (HELIUS) Study.
    Agyemang C; Snijder MB; Adjei DN; van den Born BJ; Modesti PA; Peters RJ; Stronks K; Vogt L
    Am J Kidney Dis; 2016 Mar; 67(3):391-9. PubMed ID: 26342454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acceptance of disability on death or dialysis in chronic kidney disease patients: a 3-year prospective cohort study.
    Chiang HH; Livneh H; Guo HR; Yen ML; Tsai TY
    BMC Nephrol; 2015 Dec; 16():202. PubMed ID: 26637344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse epidemiology: a spurious hypothesis or a hardcore reality?
    Kalantar-Zadeh K; Kilpatrick RD; Kuwae N; Wu DY
    Blood Purif; 2005; 23(1):57-63. PubMed ID: 15627738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hypertension in CKD.
    Horowitz B; Miskulin D; Zager P
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):88-95. PubMed ID: 25704344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
    Kalantar-Zadeh K
    Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.